New Scientist : Impact Factor & More
eISSN: 2059-5387pISSN: 0262-4079
Share this on:
Key Metrics
CiteScore 
0.2
Impact Factor
< 5
SJR
Q4Multidisciplinary
SNIP
0.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
New Scientist Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | NEW SCIENTIST LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1956 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in New Scientist
Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet).
- 14 May 2026
- Infectious diseases now
Central nervous system tuberculosis in Tunisia: clinical phenotypes from a 14-year cohort.
- 12 May 2026
- Infectious diseases now
Increasing HEV-RNA detection in the serum of acute HEV-infected immunocompetent patients, with alanine aminotransferase as a biomarker.
- 6 May 2026
- Infectious diseases now
Ceftriaxone versus cefotaxime: a scoping review of resistance selection, Clostridioides difficile risk, economic implications and environmental impacts.
- 1 May 2026
- Infectious diseases now
Temporal trends and recent disparities in nontuberculous mycobacterial mortality among older adults in the United States: A CDC WONDER analysis.
- 1 May 2026
- Infectious diseases now
Tick-borne encephalitis emergence as the third leading cause of encephalitis/meningoencephalitis in western Auvergne-Rhône-Alpes, France.
- 1 May 2026
- Infectious diseases now
Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet).
- 14 May 2026
- Infectious diseases now
Central nervous system tuberculosis in Tunisia: clinical phenotypes from a 14-year cohort.
- 12 May 2026
- Infectious diseases now
Increasing HEV-RNA detection in the serum of acute HEV-infected immunocompetent patients, with alanine aminotransferase as a biomarker.
- 6 May 2026
- Infectious diseases now
Ceftriaxone versus cefotaxime: a scoping review of resistance selection, Clostridioides difficile risk, economic implications and environmental impacts.
- 1 May 2026
- Infectious diseases now
Temporal trends and recent disparities in nontuberculous mycobacterial mortality among older adults in the United States: A CDC WONDER analysis.
- 1 May 2026
- Infectious diseases now
Tick-borne encephalitis emergence as the third leading cause of encephalitis/meningoencephalitis in western Auvergne-Rhône-Alpes, France.
- 1 May 2026
- Infectious diseases now
FAQs on New Scientist
How long has New Scientist been actively publishing? 
What is the publishing frequency of New Scientist?
How many articles did New Scientist publish last year?
What is the eISSN & pISSN for New Scientist?
What is Citescore for New Scientist?
What is SNIP score for New Scientist?
What is the SJR for New Scientist?
Who is the publisher of New Scientist?
